Neurology 1211 - Neurology Alert - Nov 01, 2008

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
Alan Z. Segal, MD
Associate Professor of Clinical Neurology
Weill-Cornell Medical College

Susan A. Gauthier, DO, MPH
Assistant Professor of Neurology
Weill-Cornell Medical College

Dara G. Jamieson, MD
Associate Professor of Clinical Neurology
Department of Neurology and Neuroscience
Weill Medical College
Cornell University

Michael Rubin, MD FRCP(C)
Professor of Clinical Neurology
Weill Medical College of Cornell University
NewYork Presbyterian Hospital

Author
Panida Piboolnurak, MD
Assistant Professor, Department of Neurology and Neuroscience
Weill-Cornell Medical College

Subjects:

  • IV Thrombolysis 3-4.5 Hours After Stroke: Time for a Change?
  • Botulinum Toxin Type A in Painful Focal Neuropathy
  • What Distinguishes Neuromyelitis Optica from Multiple Sclerosis?
  • Results of the PRoFESS Trial: Use Any Antiplatelet Agent and Get Back to the Basics
  • Statins and Myasthenia

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's physician editor, Matthew Fink, MD, assistant editors Alan Z. Segal, MD, Susan A. Gauthier, DO, MPH, Dara G. Jamieson, MD, author Panida Piboolnurak, MD, report no consultant, stockholder, speaker's bureau, research, or other relationships related to this field of study. Assistant editor Michael Rubin, MD, FRCP(C) reports that he receives grant/research support from Pfizer and that he is on the speaker's bureau for Athena Diagnostics. Peer reviewer M. Flint Beal, MD, reports no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company having ties to this field of study

Copyright 2008 AHC Media. All rights reserved.